Search

A once-daily combination treatment for those with uncontrolled Type 2 diabetes amplifies the treatment’s effects – lowering both weight and the number of hypoglycemic events, and improving quality of life and glucose control ¬– and makes participants more likely to adhere to their medications.

James Collins III, Ph.D., Associate Professor of Pharmacology at UT Southwestern Medical Center, will receive the 2023 Edith and Peter O’Donnell Award in Biological Sciences from The Academy of Medicine, Engineering and Science of Texas (TAMEST) for broadening understanding of schistosomiasis, a

UT Southwestern Medical Center has completed a five-year, $1 billion campaign to fuel its commitment to advance brain research and clinical care at its Peter O’Donnell Jr. Brain Institute, making it one of the largest brain-focused investments at a U.S. academic medical center.

UT Southwestern Medical Center and Children’s Health announced a $25 million gift from the Harry W. Bass, Jr. Foundation, directed through Southwestern Medical Foundation, in support of their $5 billion transformative joint pediatric campus under construction in Dallas’ Southwestern Medical District

The Liver Tumor Program at UT Southwestern Medical Center’s Harold C. Simmons Comprehensive Cancer Center has been selected by the National Cancer Institute as a Specialized Program of Research Excellence (SPORE).

A rare genetic disorder discovered by UT Southwestern Medical Center researchers and their colleagues can cause brain damage from dangerously low blood sugar levels and liver damage in infants, along with variable body fat loss, fatty tumors, and metabolic complications in youth and adults.

Steven McKnight, Ph.D., Professor of Biochemistry at UT Southwestern Medical Center, has been awarded the Albert Lasker Basic Medical Research Award.

Inorganic phosphate, a food additive and preservative used in up to 70 percent of food in the American diet, may be contributing to couch potato behavior.

UT Southwestern Medical Center is helping the Duff family organize a gene therapy clinical trial to treat Talia’s condition, called Charcot Marie Tooth disease, type 4J (CMT4J).

Four generations of women, who all have the same hereditary condition – familial hypercholesterolemia – form a story interwoven with the discovery of new treatments that have benefited millions of people.